The clinical trial imaging business is anticipated to augment business germination in the projection period of 2019 to 2026 reckoning to USD 611.90 million by 2026 expanding at an annual growth of 6.9% in the above-mentioned projection years. North America clinical trial imaging market is growing with factors such as increasing number of contract research organization, rising R&D expenditure and increasing prevalence of chronic diseases. However, high risk radiation causing diseases and high implementation cost of imaging systems are some of the factors that are acting as restraints and may obstruct the growth of the market in the given forecast period.
North America Clinical Trial Imaging Market Scenario
According to Data Bridge Market Research, the market for clinical trial imaging in the U.S. has the highest market share followed by Canada & Mexico. Market leader is Navitas Life Sciences which accounts an estimated market share of approximately 34.40% in the North America. The company has gained outstanding sales through providing clinical trial imaging services.
For instance,
- In January 2019, Resonance Health announced that they have entered into an agreement with EnvoyAI to distribute its FerriSmart product in the U.S. market, the product have received FDA regulatory clearance. After this agreement the company has expanded their business in the U.S. market.
Now the question is which other regions Navitas Life Sciences, BioTelemetry, Inc, RESONANCE HEALTH, IXICO plc, ICON plc are targeting? Data Bridge Market Research has estimated a large share in North America clinical trial imaging market and the market leaders targeting the U.S., Mexico, and Canada to be their next revenue pockets for 2019.
Clinical trial imaging market is becoming more competitive with companies such as Navitas Life Sciences, BioTelemetry, Inc, RESONANCE HEALTH. These are the top dominating companies in clinical trial imaging market which have maximum number of clinical trial imaging products and receiving large FDA & CE mark approval for launching new products in the market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the North America clinical trial imaging market.
For more analysis on the North America clinical trial imaging market request for a briefing with our analysts https://www.databridgemarketresearch.com/jp/speak-to-analyst/?dbmr=north-america-clinical-trial-imaging-market
North America Clinical Trial Imaging Market Development
- In May 2019, Navitas Life Cycle announces acquisition of KAI Research which strengthens its expertise in pain, diabetes, infectious diseases, and mental health and intends to create an enterprise to deliver and initiate trial outcomes.
Scope of the North America Clinical Trial Imaging Market
North America clinical trial imaging market is segmented on the basis of countries into the U.S., Canada and Mexico. All country based analysis of North America clinical trial imaging market is further analyzed based on further segmentation. On the basis of product & services, the market is segmented into services and software. On the basis of modality, the market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography, nuclear medicine, optical coherence tomography and others. On the basis of application, the market is segmented into cardiology, neurology, endocrinology, oncology, dermatology, hematology and others. On the basis of end-user, the market is segmented into contract research organization, pharmaceutical & biotechnology companies, medical device manufacturers, academic and government research institutes and others. On the basis of distributor, the market is segmented into direct sales and tender sales.
Key Pointers Covered in North America Clinical Trial Imaging Market Industry Trends and Forecast to 2026
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
- BioTelemetry, Inc
- IXICO plc
- Resonance Health
- Bioclinica
- ICON plc
- Radiant Sage LLC
- Quotient Sciences
- worldcare Clinical
- Navitas Life Sciences
- Cardiovascular Imaging Technologies
- Intrinsic Imaging
- ERT Clinical
- Perspectum Diagnostics
- Parexel International Corporation
Above are the key players covered in the report, to know about more and exhaustive list of clinical trial imaging companies’, contact us https://www.databridgemarketresearch.com/jp/toc/?dbmr=north-america-clinical-trial-imaging-market
Research Methodology: North America Clinical Trial Imaging Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Researchers, Scientists, Lab Technicians, Healthcare Professionals, Doctors
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Global Surgical Imaging Market
- Global Optical Imaging Market
- Global Vascular Imaging Market
- Global Elastography Imaging Market
- Global Veterinary imaging Market
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/jp/report-category/healthcare/